271 related articles for article (PubMed ID: 11725727)
1. Drug treatment of obesity.
Bray GA
Rev Endocr Metab Disord; 2001 Oct; 2(4):403-18. PubMed ID: 11725727
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
3. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
Richter WO
MMW Fortschr Med; 1999 Dec; 141(49-50):32-6. PubMed ID: 10726144
[TBL] [Abstract][Full Text] [Related]
4. An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action.
Nisoli E; Carruba MO
Obes Rev; 2000 Oct; 1(2):127-39. PubMed ID: 12119986
[TBL] [Abstract][Full Text] [Related]
5. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic options for the treatment of obesity.
Campbell ML; Mathys ML
Am J Health Syst Pharm; 2001 Jul; 58(14):1301-8. PubMed ID: 11471477
[TBL] [Abstract][Full Text] [Related]
7. A benefit-risk assessment of sibutramine in the management of obesity.
Nisoli E; Carruba MO
Drug Saf; 2003; 26(14):1027-48. PubMed ID: 14583064
[TBL] [Abstract][Full Text] [Related]
8. [Drug treatment of obesity].
Svendsen OL; Toubro S; Breum L; Bruun JM; Astrup AV
Ugeskr Laeger; 2006 Jan; 168(2):163-7. PubMed ID: 16403342
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for weight management.
Palatty PL; Saldanha E
J Assoc Physicians India; 2012 Mar; 60():34-40, 45. PubMed ID: 22799113
[TBL] [Abstract][Full Text] [Related]
10. Sibutramine produces dose-related weight loss.
Bray GA; Blackburn GL; Ferguson JM; Greenway FL; Jain AK; Mendel CM; Mendels J; Ryan DH; Schwartz SL; Scheinbaum ML; Seaton TB
Obes Res; 1999 Mar; 7(2):189-98. PubMed ID: 10102256
[TBL] [Abstract][Full Text] [Related]
11. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
Bays H
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
[TBL] [Abstract][Full Text] [Related]
12. Long-term pharmacotherapy for obesity.
Klein S
Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
[TBL] [Abstract][Full Text] [Related]
13. Drug treatment of obesity.
Bray GA
Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Apr; 13(1):131-48. PubMed ID: 10932681
[TBL] [Abstract][Full Text] [Related]
14. A concise review on the therapeutics of obesity.
Bray GA
Nutrition; 2000 Oct; 16(10):953-60. PubMed ID: 11054601
[TBL] [Abstract][Full Text] [Related]
15. Drug strategies for the treatment of obesity.
Alemany M; Remesar X; Fernández-López JA
IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for obesity.
Ioannides-Demos LL; Proietto J; McNeil JJ
Drugs; 2005; 65(10):1391-418. PubMed ID: 15977970
[TBL] [Abstract][Full Text] [Related]
17. The discovery and status of sibutramine as an anti-obesity drug.
Luque CA; Rey JA
Eur J Pharmacol; 2002 Apr; 440(2-3):119-28. PubMed ID: 12007530
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological therapies for obesity.
Kaplan LM
Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
[TBL] [Abstract][Full Text] [Related]
19. [Weight loss via drug therapy].
Wirth A
Internist (Berl); 2003 Mar; 44(3):359-62, 363-6. PubMed ID: 12731423
[TBL] [Abstract][Full Text] [Related]
20. Sibutramine--a review of clinical efficacy.
Lean ME
Int J Obes Relat Metab Disord; 1997 Mar; 21 Suppl 1():S30-6; discussion 37-9. PubMed ID: 9130039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
